How to Help Constipation from Ozempic: A Practical Management Guide

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists like semaglutide slow gastric emptying to reduce hunger and support weight loss—but this same mechanism can cause constipation in approximately one in four patients. Understanding why this happens and applying targeted strategies can help you manage this side effect without stopping treatment. PlexusDx provides practical, research-backed approaches to keep you on track.

Why GLP-1 Medications Cause Constipation

Semaglutide and other GLP-1 drugs work by activating receptors in your gut that signal fullness and slow the movement of food through your digestive system. This delay reduces appetite and calorie intake, which is why these medications are so effective for weight loss. However, when food moves more slowly through your intestines, your colon has more time to absorb water, making stool harder and more difficult to pass.

The constipation typically begins within the first 2–4 weeks of starting semaglutide and tends to improve over 8–12 weeks as your body adapts. Genetic factors also play a role: variations in your GLP-1 receptor gene and other peptide-pathway markers can influence how sensitive your gut is to the medication's effects. PlexusDx Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights to help identify which patients may experience stronger GI responses, allowing for more personalized management strategies from the start.

Hydration and Fiber: The First-Line Defense Against GLP-1 Constipation

Increasing your water intake is one of the most effective ways to counteract semaglutide-related constipation. Aim for at least 8–10 glasses of water daily, or roughly half your body weight in ounces. Proper hydration keeps stool soft and makes it easier to pass, even when gastric emptying is slowed. Many patients find that drinking water consistently throughout the day—rather than in large amounts at once—produces the best results.

Soluble fiber supplements like psyllium husk or methylcellulose can also provide relief without the bloating that sometimes occurs with insoluble fiber. Start with a low dose (1 teaspoon daily) and gradually increase over one week to allow your system to adjust. Pair fiber intake with plenty of water; fiber without adequate hydration can actually worsen constipation. Focus on water-rich whole foods like cucumbers, zucchini, and berries, which provide both fiber and hydration in a natural form that GLP-1 patients typically tolerate well.

Physical Activity and Movement: Stimulating Your Digestive System

Regular physical activity directly stimulates intestinal contractions and promotes bowel regularity, independent of medication. Gentle movement like walking for 20–30 minutes after meals has been shown in multiple studies to improve gastric emptying and reduce GI side effects. You don't need intense exercise; moderate-intensity activity performed consistently is more effective than occasional high-intensity workouts for managing constipation.

Yoga poses that gently massage the abdomen—such as cat-cow, child's pose, and supine twists—can also encourage bowel movement. Even light stretching or a slow walk after breakfast, lunch, and dinner can make a measurable difference in your symptoms. Combined with the appetite suppression from semaglutide, this increased movement creates a synergistic benefit: you eat less, digest more gradually, and your muscles support natural bowel function.

Over-the-Counter and Prescription Options for Persistent Constipation

If diet, hydration, and exercise don't fully resolve your symptoms, over-the-counter stool softeners like docusate (Colace) are gentle and generally well-tolerated by GLP-1 patients. Osmotic laxatives such as magnesium citrate or polyethylene glycol (MiraLAX) draw water into the bowel and typically take 12–24 hours to work. Avoid stimulant laxatives like senna or bisacodyl long-term, as your gut can become dependent on them, making natural bowel function harder over time.

Prucalopride is a selective serotonin 5-HT4 receptor agonist approved by the FDA specifically for chronic constipation and has shown promise in small studies of GLP-1 users. If constipation remains severe after 2–4 weeks of conservative management, consult your healthcare provider about prescription options. Many patients find that combining one or two gentle strategies—such as increased hydration plus a stool softener—provides effective relief without side effects. Track your symptoms in a log to share with your provider, as patterns help identify which approach works best for your body.

How PlexusDx Supports You Through GLP-1 Side Effect Management

PlexusDx compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan) through licensed 503A compounding pharmacies—a cost-effective way to access prescription-strength weight loss therapy without insurance. Importantly, your dose may need to go up as your body adjusts to treatment. Your price won't: PlexusDx maintains flat monthly pricing across all commitment tiers, so you won't face surprise increases as your dose is optimized.

The PlexusDx Precision Peptide Genetic Test ($298) maps 14 peptide pathways and analyzes key genetic variants—including MC4R rs17782313, and others—that influence your individual response to GLP-1 therapy. Understanding your genetic profile helps you and your provider anticipate side effects like constipation, adjust your starting dose if needed, and select complementary strategies tailored to your biology. PlexusDx serves all 50 states with no membership fees and accepts HSA/FSA accounts, making personalized GLP-1 therapy accessible and affordable.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long does constipation from semaglutide typically last?

Most patients experience peak constipation during weeks 2–4 of starting semaglutide, with gradual improvement over 8–12 weeks as the body adapts. However, some individuals continue to experience mild symptoms throughout treatment. Implementing hydration, fiber, and movement strategies from day one can significantly shorten the symptomatic period and improve comfort.

Can I take a stool softener while on GLP-1 medication?

Yes, over-the-counter stool softeners like docusate are safe and effective for GLP-1 patients. In fact, many healthcare providers recommend starting a stool softener preventively when beginning semaglutide. Always inform your provider of any over-the-counter medications or supplements you're using to ensure no interactions with your GLP-1 therapy.

Is constipation a reason to stop taking semaglutide?

Constipation is rarely a reason to discontinue semaglutide, as it is manageable through diet, hydration, exercise, and over-the-counter support. Most patients find that the benefits of sustained weight loss and metabolic improvement outweigh temporary GI discomfort, especially when practical strategies are applied. If severe constipation persists despite interventions, consult your provider about dose adjustments or alternative formulations like oral semaglutide.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does PlexusDx semaglutide cost, and is it covered by insurance?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and maintains that flat rate across all commitment tiers—your dose may increase, but your price won't. PlexusDx serves all 50 states without requiring insurance, and your account is HSA/FSA eligible. Add the Precision Peptide Genetic Test ($298) to unlock personalized insights into your GLP-1 response and side effect management.

Related Reading

• Weight Management Peptide Pathway Guide
• What Are The Genetic Factors In Constipation And Effective Management
• How Do Genetic Markers Affect Psoriasis Development And Guide Personalized Management
• Lifemd Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.